Changes in the Crohn's Disease Activity Index and Safety of Administering Saccharomyces Boulardii in Patients with Crohn's Disease in Clinical Remission: A Single Hospital-based Retrospective Cohort Study.
The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi（2020）
摘要
In patients with CD in remission, appears to improve the CDAI, BMI, serum Hb, and total cholesterol level without safety issues. Further randomized controlled studies will be needed.
更多查看译文
关键词
Crohn disease,Inflammatory bowel diseases,Probiotics,Saccharomyces boulardii
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要